TrialBreast cancer research : BCR2016

Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer.

Ian E Krop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.